Loading financial data...

Apimeds Pharmaceuticals US, Inc.

APUSSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1894525

DEFM14C

INFORMATION STATEMENT

Filed: Feb 27, 2026

View on SEC

425

AMENDMENT NO. 2 TO FORM 8-K

Filed: Feb 17, 2026

View on SEC

8-K/A

AMENDMENT NO. 2 TO FORM 8-K

Filed: Feb 17, 2026 | Report: Dec 1, 2025

INFORMATION STATEMENT

Filed: Jan 16, 2026 | Report: Jan 16, 2026

View on SEC

8-K

CURRENT REPORT

Filed: Jan 2, 2026 | Report: Dec 30, 2025

View on SEC

8-K

CURRENT REPORT

Filed: Dec 10, 2025 | Report: Dec 5, 2025

View on SEC

8-K/A

AMENDMENT NO. 1 TO FORM 8-K

Filed: Dec 10, 2025 | Report: Dec 1, 2025

Filed: Dec 2, 2025 | Report: Dec 1, 2025

View on SEC

4/A

PRIMARY DOCUMENT

Filed: Nov 21, 2025 | Report: May 12, 2024

View on SEC

8-K

CURRENT REPORT

Filed: Nov 18, 2025 | Report: Nov 13, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Nov 13, 2025 | Report: Nov 11, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Nov 13, 2025 | Report: Nov 11, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Nov 13, 2025 | Report: Nov 11, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Nov 13, 2025 | Report: Nov 11, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Nov 13, 2025 | Report: Nov 11, 2025

View on SEC

10-Q

QUARTERLY REPORT

Filed: Nov 12, 2025 | Report: Sep 30, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 24, 2025 | Report: Oct 15, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 21, 2025 | Report: Oct 15, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 17, 2025 | Report: Oct 15, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 17, 2025 | Report: Oct 15, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 17, 2025 | Report: Oct 15, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 17, 2025 | Report: Oct 15, 2025

View on SEC

PRIMARY DOCUMENT

Filed: Oct 17, 2025 | Report: Oct 15, 2025

View on SEC

8-K

CURRENT REPORT

Filed: Oct 16, 2025 | Report: Oct 15, 2025

View on SEC

10-Q

QUARTERLY REPORT

Filed: Aug 19, 2025 | Report: Jun 30, 2025

View on SEC

NT 10-Q

NOTIFICATION OF LATE FILING

Filed: Aug 14, 2025 | Report: Jun 30, 2025

View on SEC

8-K

CURRENT REPORT

Filed: Jul 16, 2025 | Report: Jul 15, 2025

View on SEC

4/A

PRIMARY DOCUMENT

Filed: Jun 11, 2025 | Report: May 12, 2025

View on SEC

3/A

PRIMARY DOCUMENT

Filed: Jun 11, 2025 | Report: Mar 4, 2025

View on SEC

8-K

CURRENT REPORT

Filed: Jun 5, 2025 | Report: May 30, 2025

View on SEC

S-8

REGISTRATION STATEMENT

Filed: May 23, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

8-K

CURRENT REPORT

Filed: May 20, 2025 | Report: May 16, 2025

View on SEC

10-Q

QUARTERLY REPORT

Filed: May 20, 2025 | Report: Mar 31, 2025

Filed: May 15, 2025 | Report: May 13, 2025

View on SEC

NT 10-Q

NOTIFICATION OF LATE FILING

Filed: May 15, 2025 | Report: Mar 31, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 14, 2025 | Report: May 12, 2025

View on SEC

PRIMARY DOCUMENT

Filed: May 14, 2025 | Report: May 12, 2025

View on SEC

3/A

PRIMARY DOCUMENT

Filed: May 14, 2025 | Report: Mar 4, 2025

View on SEC

8-K

CURRENT REPORT

Filed: May 12, 2025 | Report: May 8, 2025

View on SEC

Build with this data

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)

Get API Key (Free)

Apimeds Pharmaceuticals US, Inc. (APUS) SEC Filings | Global Financial Data